<- Go Home

Medios AG

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment includes cytostatic infusion preparations, antibody therapies, virostatic and antibiotic medications, parenteral nutrition solutions, and investigational medicinal products. Medios AG was founded in 2016 and is headquartered in Berlin, Germany.

Market Cap

EUR 383.2M

Volume

32.1K

Cash and Equivalents

EUR 81.7M

EBITDA

EUR 49.8M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

EUR 113.7M

Profit Margin

6.19%

52 Week High

EUR 18.50

52 Week Low

EUR 13.74

Dividend

N/A

Price / Book Value

0.73

Price / Earnings

22.53

Price / Tangible Book Value

-20.71

Enterprise Value

EUR 335.6M

Enterprise Value / EBITDA

6.37

Operating Income

EUR 31.6M

Return on Equity

3.32%

Return on Assets

2.53

Cash and Short Term Investments

EUR 81.7M

Debt

EUR 34.1M

Equity

EUR 502.9M

Revenue

EUR 1.8B

Unlevered FCF

EUR 317.0M

Sector

Health Care Providers and Services

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches